AI assistant
Sending…
PROKIDNEY CORP. — Director's Dealing 2025
Jun 2, 2025
32485_dirs_2025-06-02_ca20e5bc-f7ac-4b86-96c1-fdf32522345c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PROKIDNEY CORP. (PROK)
CIK: 0001850270
Period of Report: 2025-05-29
Reporting Person: Lotvin Alan (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-05-29 | Director stock option (right to buy) | $0.72 | A | 125862 | Acquired | 2035-05-29 | Class A Ordinary Shares (125862) | Direct |
Footnotes
F1: These options were granted under the Issuer's non-employee director compensation policy.
F2: The options will vest in full on the sooner of the one-year anniversary of the date of grant or the date of Company's next annual general shareholder meeting.
More from PROKIDNEY CORP.
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 15
Annual Report
2026
Apr 17
Regulatory Filings
2026
Mar 18
Regulatory Filings
2026
Mar 18
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3